http://www.acc.org/Feed?clinicalTopicID=2d1edb86-1b6a-4771-8577-42769c4272ef Clinical Topic Feed: Invasive Cardiovascular Angiography and Intervention en /Latest-in-Cardiology/Articles/2026/03/04/12/02/Extended-DAPT-in-Multivessel-CAD The DAPT-MVD (Dual Antiplatelet Therapy in Patients With Coronary Multi-Vessel Disease) trial was a multicenter, randomized, open-label study in China designed to assess whether extending dual antiplatelet therapy (DAPT) beyond 12 months provides additional benefit for patients with multivessel coronary artery disease (CAD)... 1772647140000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/04/14/11/eagles-eye-view-04mar2025 In this week’s View, Dr. Eagle looks at increased one-year mortality in younger patients undergoing transcatheter aortic valve replacement (TAVR). 1772636400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/03/16/25/accel-lite-03mar2025 In this interview, Cindy L. Grines MD, FACC and Stephen Juraschek, MD, PhD discuss how findings from the GOFRESH trial may be used to improve hypertension management and overall patient care. 1772555340000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/02/17/40/Key-Insights-From-the-ANDES-Trial The ANDES (Antithrombotic Therapy After Left Atrial Appendage Closure: Direct Oral Anticoagulants vs Dual Antiplatelet Therapy) trial results demonstrated that, in patients with nonvalvular atrial fibrillation who underwent left atrial appendage closure (LAAC), short-term direct oral anticoagulant (DOAC) therapy... 1772478060000 Articles and Stories /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1772469660000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/01/01/JACC-in-a-Flash Featured topics and Editors' Picks from all of ACC's JACC Journals. 1772370600000 Articles and Stories /Latest-in-Cardiology/Articles/2026/02/26/17/54/Medtronic-Clinician-Update-on-New-Evolut-Valve-Data-Reinforces-Need-For-Patient-Dialogue Medtronic has issued a letter and developed web resources providing an update on long-term reintervention rates associated with its Evolut R and Evolut PRO transcatheter heart valves, drawing on complete six-year and partial seven-year follow-up data from the Evolut Low-Risk Trial published on Feb. 16 in JACC. 1772128800000 Articles and Stories /Latest-in-Cardiology/Articles/2026/02/24/16/30/eagles-eye-view-24feb2025 In this week’s View, Dr. Eagle looks at findings from the Evolut Low Risk trial in which self-expanding transcatheter aortic valve replacement (TAVR) versus surgery at six years in low-risk patients with aortic stenosis (AS) is considered. 1772031600000 Articles and Stories /Latest-in-Cardiology/Articles/2026/02/19/11/58/Hot-Topics-in-Congenital-and-Pediatric-Cardiology-in-the-Year-2025 The pace of innovation in congenital and pediatric cardiology continued to accelerate in 2025, shaped by practice‑defining guidelines, multicenter investigations, and growing bench‑to‑bedside translation. 1771850460000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/02/20/14/58/Increased-One-Year-Mortality-in-Younger-Patients-Undergoing-TAVR-NCDR-Study Patient case-mix for TAVR has evolved to include more low-risk candidates since the 2019 indication expansion, and younger patients, while more likely to be classified as low-risk, exhibit increased one-year mortality after risk adjustment, according to a Brief Report recently published in JACC. 1771599480000 Articles and Stories